Es gab 50 kürzliche Insider-Transaktionen für Plus Therapeutics, Inc. (PSTV), darunter 48 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.16M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Hedrick Marc H, Sims Andrew John Hugh Macintyre, Andrews Ronald Asbury. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PSTV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Hedrick Marc H |
Chief Executive Officer |
Optionsausübung |
159,681 |
- |
- |
499,468 |
| 2026-04-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Optionsausübung |
38,323 |
- |
- |
144,784 |
| 2026-03-20 |
Andrews Ronald Asbury |
Director |
Unbekannt |
- |
- |
- |
- |
| 2026-02-25 |
Hedrick Marc H |
Chief Executive Officer |
RSU-Zuteilung |
2,419,582 |
$0.28 |
$677.48K |
2,419,582 |
| 2026-02-25 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
RSU-Zuteilung |
349,541 |
$0.28 |
$97.87K |
349,541 |
| 2026-01-01 |
Hedrick Marc H |
Chief Executive Officer |
Optionsausübung |
159,681 |
- |
- |
339,787 |
| 2026-01-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Optionsausübung |
38,323 |
- |
- |
106,461 |
| 2025-11-04 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Informierter Kauf |
20,000 |
$0.51 |
$10.2K |
68,138 |
| 2025-10-01 |
Hedrick Marc H |
Chief Executive Officer |
Optionsausübung |
159,681 |
- |
- |
180,106 |
| 2025-10-01 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Optionsausübung |
38,323 |
- |
- |
48,138 |
| 2025-08-22 |
Lenk Robert P |
Director |
Informierter Kauf |
110,000 |
$0.49 |
$53.78K |
139,327 |
| 2025-08-13 |
Hedrick Marc H |
Chief Executive Officer |
RSU-Zuteilung |
1,916,168 |
- |
- |
1,916,168 |
| 2025-08-13 |
Hawkins Richard J |
Director |
RSU-Zuteilung |
397,794 |
$0.57 |
$228.49K |
397,794 |
| 2025-08-13 |
Lenk Robert P |
Director |
RSU-Zuteilung |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Guse Kyle |
Director |
RSU-Zuteilung |
40,000 |
$0.57 |
$22.98K |
40,000 |
| 2025-08-13 |
Van Es-johansson An |
Director |
RSU-Zuteilung |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-08-13 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
RSU-Zuteilung |
459,878 |
- |
- |
459,878 |
| 2025-08-13 |
Clowes Howard |
Director |
RSU-Zuteilung |
297,794 |
$0.57 |
$171.05K |
297,794 |
| 2025-04-18 |
Guse Kyle |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-02-18 |
Hedrick Marc H |
Chief Executive Officer |
RSU-Zuteilung |
400,489 |
$1.18 |
$472.58K |
400,489 |
| 2025-02-18 |
Hawkins Richard J |
Director |
RSU-Zuteilung |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Lenk Robert P |
Director |
RSU-Zuteilung |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Petersen Greg |
Director |
RSU-Zuteilung |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Van Es-johansson An |
Director |
RSU-Zuteilung |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2025-02-18 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
RSU-Zuteilung |
60,020 |
$1.18 |
$70.82K |
60,020 |
| 2025-02-18 |
Clowes Howard |
Director |
RSU-Zuteilung |
40,122 |
$1.18 |
$47.34K |
40,122 |
| 2024-09-13 |
Hawkins Richard J |
Director |
Informierter Kauf |
4,000 |
$1.50 |
$6K |
15,188 |
| 2024-09-12 |
Hawkins Richard J |
Director |
Informierter Kauf |
6,285 |
$1.35 |
$8.51K |
11,188 |
| 2024-09-11 |
Hedrick Marc H |
Chief Executive Officer |
RSU-Zuteilung |
197,595 |
$1.26 |
$248.97K |
197,595 |
| 2024-09-11 |
Hawkins Richard J |
Director |
RSU-Zuteilung |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Lenk Robert P |
Director |
RSU-Zuteilung |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
RSU-Zuteilung |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Van Es-johansson An |
Director |
RSU-Zuteilung |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
RSU-Zuteilung |
46,074 |
$1.26 |
$58.05K |
46,074 |
| 2024-09-11 |
Clowes Howard |
Director |
RSU-Zuteilung |
3,650 |
$1.26 |
$4.6K |
3,650 |
| 2024-09-11 |
Petersen Greg |
Director |
Informierter Kauf |
12,500 |
$1.35 |
$16.88K |
48,921 |
| 2024-09-11 |
Clowes Howard |
Director |
Informierter Kauf |
5,000 |
$1.34 |
$6.68K |
26,497 |
| 2024-09-10 |
Hedrick Marc H |
Chief Executive Officer |
Informierter Kauf |
8,000 |
$1.23 |
$9.84K |
20,425 |
| 2024-09-10 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Informierter Kauf |
4,098 |
$1.27 |
$5.2K |
9,815 |
| 2024-05-08 |
Hedrick Marc H |
Chief Executive Officer |
Informierter Kauf |
12,255 |
$2.04 |
$25K |
12,425 |
| 2024-05-08 |
Hawkins Richard J |
Director |
Informierter Kauf |
4,902 |
$2.04 |
$10K |
4,903 |
| 2024-05-08 |
Lenk Robert P |
Director |
RSU-Zuteilung |
8,334 |
$1.79 |
$14.92K |
8,334 |
| 2024-05-08 |
Petersen Greg |
Director |
RSU-Zuteilung |
24,510 |
$1.79 |
$43.87K |
24,510 |
| 2024-05-08 |
Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
Informierter Kauf |
4,902 |
$2.04 |
$10K |
5,717 |
| 2024-05-08 |
Clowes Howard |
Director |
RSU-Zuteilung |
19,608 |
$1.79 |
$35.1K |
19,608 |
| 2024-02-22 |
Hedrick Marc H |
Chief Executive Officer |
RSU-Zuteilung |
94,012 |
$2.03 |
$190.84K |
94,012 |
| 2024-02-22 |
Hawkins Richard J |
Director |
RSU-Zuteilung |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lenk Robert P |
Director |
RSU-Zuteilung |
2,250 |
$2.03 |
$4.57K |
2,250 |
| 2024-02-22 |
Lafrance Norman D. |
Chief Medical Officer |
RSU-Zuteilung |
24,073 |
$2.03 |
$48.87K |
24,073 |
| 2024-02-22 |
Petersen Greg |
Director |
RSU-Zuteilung |
2,250 |
$2.03 |
$4.57K |
2,250 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
